NKCx Histopathological outcome* within 12 months after cervix cytology in 2021 |
501 Sahlgrenska |
Benign | LSIL | HSIL | AIS | Cancer | Other | PAD missing | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytologi | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel |
Benign sample | 1595 | 5.3% | 633 | 2.1% | 76 | 0.3% | 11 | 0.0% | 4 | 0.0% | 15 | 0.0% | 27916 | 92.3% | 30250 | 100.0% |
ASCUS | 1328 | 28.8% | 1250 | 27.1% | 390 | 8.4% | 5 | 0.1% | 5 | 0.1% | 21 | 0.5% | 1618 | 35.0% | 4617 | 100.0% |
LSIL | 251 | 23.3% | 434 | 40.4% | 170 | 15.8% | . | . | 2 | 0.2% | 10 | 0.9% | 208 | 19.3% | 1075 | 100.0% |
Atypical glandular cells/AGC | 3 | 10.3% | 5 | 17.2% | 2 | 6.9% | 6 | 20.7% | 7 | 24.1% | 2 | 6.9% | 4 | 13.8% | 29 | 100.0% |
Unclear atypia | 3 | 50.0% | 2 | 33.3% | . | . | . | . | . | . | 1 | 16.7% | . | . | 6 | 100.0% |
ASC-H | 18 | 8.3% | 63 | 29.0% | 120 | 55.3% | 4 | 1.8% | 5 | 2.3% | 3 | 1.4% | 4 | 1.8% | 217 | 100.0% |
HSIL | 16 | 4.4% | 37 | 10.1% | 283 | 77.5% | 4 | 1.1% | 16 | 4.4% | 1 | 0.3% | 8 | 2.2% | 365 | 100.0% |
Suspected Adenocarcinom | 1 | 7.7% | 1 | 7.7% | . | . | 2 | 15.4% | 6 | 46.2% | . | . | 3 | 23.1% | 13 | 100.0% |
Squamous cell cancer | . | . | . | . | . | . | . | . | 2 | 50.0% | . | . | 2 | 50.0% | 4 | 100.0% |
Totalt | 3215 | 8.8% | 2425 | 6.6% | 1041 | 2.8% | 32 | 0.1% | 47 | 0.1% | 53 | 0.1% | 29763 | 81.4% | 36576 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80413, M80703, M80706, M81403, M84616 |